Optimization of Liquid Fermentation Conditions for N-Glycosylated Ganoderma lucidum Immunomodulatory Protein Production by an Engineered Pichia pastoris
Journal of Pure and Applied Microbiology · 01.03.2025 · 19 (1) · 476-484
DOI: 10.22207/jpam.19.1.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pure and Applied Microbiology, online erschienen am 27.02.2025. Verfasst von Yan Liu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The Ganoderma lucidum immunomodulatory protein (FIP-glu) holds promise as a potential anti-tumor therapeutic agent. Enhancing the expression and stability of the engineered yeast strain is crucial for its industrial viability. This study focused on optimizing the fermentation parameters to produce an N-glycosylated protein, designated T36N, using the engineered Pichia pastoris GS115 strain with a mutant gene FIP-glu_T36N, a FIP-glu variant with an N-linked glycan modification. The response surface methodology (RSM) was employed to investigate the fermentation parameters that influence the yield of the N-glycosylated protein. Initially, the impact of fermentation duration on the optical density (OD600) and protein yield of P. pastoris GS115 were assessed, leading to the determination of a 96-hour fermentation period as optimal. Subsequently, the interplay among fermentation temperature, initial pH, and methanol concentration on protein yield was explored. The RSM analysis revealed the most favorable conditions for fermentation: a temperature of 26 °C, an initial pH of 6.5, and a methanol concentration of 1.00%. Verification tests confirmed that under these optimized conditions, the T36N yield peaked at 346.64 ± 3.47 mg.L-1, marking a 32.9% increase. The results underscored the capability of achieving high yields of T36N through the optimization of P. pastoris GS115 fermentation conditions. This research laid the groundwork for the industrial-scale production of N-glycosylated immunomodulatory proteins, offering a platform for the development of novel therapeutic agents.
Zitieren
APA
Liu, Y., Guo, Z., Yang, J., & Zhou, X. (2025). Optimization of Liquid Fermentation Conditions for N-Glycosylated Ganoderma lucidum Immunomodulatory Protein Production by an Engineered Pichia pastoris. Journal of Pure and Applied Microbiology, 19(1), 476-484. https://doi.org/10.22207/jpam.19.1.38
Vancouver
Liu Y, Guo Z, Yang J, Zhou X. Optimization of Liquid Fermentation Conditions for N-Glycosylated Ganoderma lucidum Immunomodulatory Protein Production by an Engineered Pichia pastoris. Journal of Pure and Applied Microbiology. 2025;19(1):476-484. doi:10.22207/jpam.19.1.38
BibTeX
@article{Liu2025,
author = {Liu, Yan and Guo, Zhijian and Yang, Jiayi and Zhou, Xuanwei},
title = {Optimization of Liquid Fermentation Conditions for N-Glycosylated Ganoderma lucidum Immunomodulatory Protein Production by an Engineered Pichia pastoris},
journal = {Journal of Pure and Applied Microbiology},
year = {2025},
volume = {19},
number = {1},
pages = {476--484},
doi = {10.22207/jpam.19.1.38}
}
EUVIMED